Streeting announced a collaboration with the world's largest pharmaceutical company, Lilly, which will include a five-year ...

Europe is seemingly cracking down on weight-loss drugs like Wegovy; but the French agency cited deductive reasoning, ...

Chronic back pain has become a major health issue. The persistent pain in the back can be caused due to several reasons and these include poor posture, muscle strain and arthritis among others. Read ...

The UK government starts a trial offering weight loss drug Mounjaro to unemployed obese individuals to improve health and ...

The Chancellor would riposte that she has changed her mind because the facts have changed: she must now raise £40bn to ...

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

The latest plan to tackle obesity in the UK could also help to get people back into work, but what are the risks?

The UK Government is considering using weight-loss drugs to help support obese people in returning to work and reduce the high rates of long-term sickness, which have become a significant strain on ...

The latest plan to tackle obesity in the UK could also help to get people back into work, but what are the risks?

Weight loss drugs such as Wegovy have risen in popularity in recent months - but how exactly does it work and what are the side effects?

All of this means Lilly investors shouldn't panic. Even in the "worst case," Lilly's weight loss drugs have driven major revenue growth, and this is likely to continue -- whether compounders halt ...

U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a ...